Exhaustive Study Guide on Prion Strains, Species Barriers, and Clinical Manifestations

Determinants of Prion Protein Strains

  • Definition of Prion Strains: Strains are not determined by DNA or RNA mutations because prions are solely proteinaceous. Instead, the characteristics of a strain are dictated by the misfolding or the specific shape of the protein.

  • Mechanisms for Strain Recognition: There are two primary factors that characterize and allow for the recognition of different prion strains:     * Conformation: This refers to the specific three-dimensional shape of the misfolded prion protein (PrPScPrP^{Sc}). Different folding patterns can emerge depending on the species involved or the origin of the protein.     * Glycoforms: This relates to the carbohydrate structures attached to the protein. The number and composition of these carbohydrate molecules determine specific strain attributes.

  • Glycosylation States: Prion proteins can exist in different states of glycosylation:     * Mono-glycosylated: Containing one molecule of carbohydrate.     * Di-glycosylated: Containing two molecules of carbohydrate.     * Non-glycosylated: Containing no carbohydrate molecules.

  • Strain Differentiation via Glycoforms: By analyzing the percentage of di-glycosylated molecules relative to other carbohydrate distributions, researchers can identify distinct types. For instance, the percentage of di-glycosylated molecules in Type 4 is significantly higher than in Type 1 or Type 2, providing a marker for different strains.

The Species Barrier in Prion Transmission

  • Concept of Species Barrier: This term describes the relative ease or difficulty with which a prion disease is transmitted between different species compared to transmission within the same species.

  • Intra-species Transmission: Transmission from animal to animal within the same species (e.g., mouse-to-mouse, hamster-to-hamster, or cow-to-cow) occurs easily. The disease develops quickly because the normal cellular prion protein (PrPCPrP^C) of the host is identical or very similar in sequence to the infectious prion protein, allowing for easy conversion.

  • Inter-species Transmission: Transmission between different species (e.g., mouse to hamster or cattle to human) is much more difficult.     * Characteristics of Cross-Species Transmission: It results in a less progressive disease, requires a significantly longer incubation period, and necessitates a much higher infectious dose to establish the disease.     * Fundamental Reason for the Barrier: The amino acid sequences of the normal cellular prion protein (PrPCPrP^C) differ between species. These variations in sequence make it difficult for an infectious prion from one species to template the misfolding of a normal protein in a different species.

  • Case Study: BSE in the UK:     * Over 1imes1061 imes 10^6 (one million) cattle were infected with Bovina spongiformis fallopathy (BSE) in the UK.     * Despite widespread exposure, fewer than 200200 humans were infected.     * This discrepancy is attributed to the species barrier and the requirement for a large dose of the infectious agent.

  • Tissue Risk and Pathogenesis: The highest concentration of infectious prions is found in the brain. Consumption of muscle tissue is significantly less risky than consuming brain tissue, which contains the large doses necessary to overcome the human species barrier.

Scrapie in Sheep

  • Host: Specifically affects sheep.

  • Identification and Clinical Signs:     * Loss of Condition: Significant weight loss and emaciation.     * Wool Loss: Caused by intense itching, leading the sheep to rub and scratch against objects (hence the name "Scrapie").     * Nervous Signs: Includes ataxia (incoordination) and tremors.

  • Epidemiological Data:     * Incubation Period: Long, ranging from 22 to 55 years.     * Susceptible Age: Sheep aged 22 to 55 years are most at risk.     * Geographic Distribution: Endemic in the UK. Positive cases have been recorded in Saudi Arabia and Yemen. There is currently no recorded research or evidence of the disease in the UAE.

  • Genetic Susceptibility: The genetic constitution or breed of the sheep influences how susceptible they are to the disease.

  • Progression: Following the appearance of clinical nervous signs, death typically occurs within 11 to 33 months. There is no known treatment.

Bovine Spongiform Encephalopathy (BSE) and Cattle

  • Host and Zoonotic Potential: Primarily affects cattle but is zoonotic, meaning it can be transmitted to humans (resulting in variant Creutzfeldt-Jakob Disease) through the consumption of infected meat and brain tissue.

  • Clinical Signs: Characterized by ataxia, nervous/aggressive behavior ("mad cow"), and loss of condition.

  • Progression to Death: Once clinical signs appear, death occurs within 11 to 66 months.

  • Host Range Expansion: BSE has been known to spread to other animals including sheep, goats, and cats.

  • The Transmission Pathway (Meat and Bone Meal):     * The primary cause for the epidemic in the UK in 19851985 was the use of "Meat and Bone Meal" (MBM), a processed feed made from rendering animal remains.     * The epidemic led to a ban on feeding bone and meat meal to livestock.

  • Pathological Course in the Body:     1. Oral ingestion.     2. Migration to lymphoid tissues.     3. Entry into the autonomic nervous system.     4. Arrival at the central nervous system (the brain).

  • Genetic Factors: Unlike sheep, there is little evidence to suggest that the genetic characteristic of individual cattle has a significant effect on disease susceptibility.

Chronic Wasting Disease (CWD) in Wild Animals

  • Host: Found in wild animals, specifically deers and Rocky Mountain Elk.

  • Naming and Symptoms: Defined by severe emaciation (chronic wasting), loss of condition, and various nervous signs.

  • Geographic Focus: Primarily recorded in the USA.

  • Incubation Period: Shorter than other prion diseases, approximately 1616 months (roughly 1.51.5 years).

  • Zoonotic Status: It is currently unknown if Chronic Wasting Disease can be transmitted to humans; no evidence currently confirms zoonotic transmission similar to BSE.

Human Prion Disease: Variant Creutzfeldt-Jakob Disease (vCJD)

  • Distinction of Variant CJD: The term "variant" is used specifically for the pathological condition in humans caused by eating meat from cattle infected with BSE. Other forms of CJD exist, such as those caused by spontaneous mutation or medical instruments.

  • Kuru: A historically notable form of human prion disease transmitted through the consumption of infected human brain tissue.

  • Clinical Signs of vCJD:     * Psychological/Neurological: Depression, anxiety, delusions, hallucinations, and dementia (memory and speech problems).     * Motor/Physical: Ataxia, chorea (uncontrolled "dancing" movements of fingers, hands, and legs), and myoclonus (involuntary muscle spasms).

  • Microscopic Diagnosis:     * Spongiform Changes: The brain appears full of holes under a microscope.     * Floured Plaque: A characteristic diagnostic feature indicating an aggregation of prion deposits surrounding the plaque part of the tissue.

General Characteristics and Diagnosis of Prions

  • Unique Characteristics:     * No DNA or RNA present.     * No inflammatory response or antibody production by the host immune system.     * Very long incubation periods (often measured in years, except for CWD which is roughly 1.51.5 years).     * They are zoonotic agents.     * Mechanism of Infection: The infectious misfolded protein (PrPScPrP^{Sc}) binds to the normal cellular protein (PrPCPrP^C) and catalyzes its conversion into the infectious form.

  • Reason for Lack of Immune Response: The immune system does check the amino acid sequence, which is identical to the host's normal proteins. Because it is a normal protein sequence that is simply misfolded, the body does not recognize it as a foreign microorganism or "strange body."

  • Inability of PCR: PCR and similar DNA-based tests are ineffective because prions lack genetic material. Diagnosis must rely on other methods.

  • Diagnostic Methods:     * Bioassay (Bio-SC): Injecting a sample into a lab animal and monitoring for clinical signs.     * Histopathology: Examining brain tissue after death to look for spongiform holes and "astrocytic gliosis" (an overproduction of glial cells).     * Enzyme Resistance Test: Normal prion proteins (PrPCPrP^C) are sensitive to protease enzymes (e.g., Proteinase K) and will disappear when treated. Infectious prions (PrPScPrP^{Sc}) are resistant to these enzymes and will remain visible in the sample after treatment.